Of note, TIGIT and PD-1 expression levels were found to be significantly increased on CD8+ T cells compared with CD4+ T cells in patients with MDS, whereas no significant differences were observed for CD226 expression levels between CD8+ T and CD4+ T cells (Table 3). This evidence concerns the gene CD8A and myelodysplastic syndrome.